IndraLab

Statements

SB 203580 inhibits NLRP3. 1 / 1

| 1

reach

"SB203580 pretreatment significantly reversed the LPS induced upregulation of NLRP3, cleaved caspase-1 and TLR2, indicating a beneficial role of blockage of the p38 MAPK signaling pathway in reducing the formation of the NLRP3 inflammasome and pyroptosis."

30152849

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

SB 203580 inhibits NLRP3. 1 / 1

INDRA sources:

Databases

Reading